Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001012975-26-000138·ORAMED PHARMACEUTICALS INC.
Schedule 13G ownership disclosure
SCILEX HOLDING CO
Common Stock, par value $0.0001 per share · CUSIP: 80880W205
Event date: 2025-12-31
- Filing-level shares
- 437,510
- Percent of class
- 4.9%
- Oramed Pharmaceuticals Inc.
Shares: 437,510 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001012975-26-000138
- Form type
- SCHEDULE 13G/A
- Filer
- ORAMED PHARMACEUTICALS INC.
- CIK
- CIK 1176309
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership